Genomic sequencing identified pathogenic variants in patients with chronic immune thrombocytopenia, which could help clinicians improve diagnostic accuracy.
A recent study showed that scheduled follow-ups played a limited role for DLBCL relapse detection, emphasizing a need for alternative surveillance strategies.
A study in Cancer compared the accuracy of five risk scores for time to treatment in CLL, including the IPS-E, CR0, AIPS-E, CLL-IPI, and Barcelona-Brno.